GENETIC · Unmapped registry intervention
AdNRGM
Find medicine records ·
Find other trials using this name
Clinical trial
A Clinical Trial of AdNRGM Plus CB1954 in Prostate Cancer
NCT04374240
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Clinical Trial of AdNRGM Plus CB1954 in Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
AdNRGMGENETIC
Sponsors & collaborators
University of Birminghamlead sponsor
Janssen, LPcollaborator
Department of Health, United Kingdomcollaborator
Medical Research Councilcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04374240 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.